{
  "id": 442417,
  "title": "StockWatch: Lilly Rises on Revenue Leap; Analysts High on Krystal Despite Revenue Miss",
  "url": "https://urgent.news/2026/08/10/stockwatch-lilly-rises-on-revenue-leap-analysts-high-on-krystal",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-10T04:37:02.000Z",
  "source": {
    "name": "GEN Biotechnology",
    "slug": "gen-biotechnology",
    "url": "https://www.genengnews.com/topics/translational-medicine/stockwatch-lilly-rises-on-revenue-leap-analysts-high-on-krystal-despite-revenue-miss/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Lilly now expects to rack up between $85 billion and $87 billion in revenue this year, up 2.4% to 3.7% from its previous range of between $82 billion and $85 billion. That change raised the midpoint of Lilly’s revenue forecast from $85.5 billion to $86 billion. The post StockWatch: Lilly Rises on Revenue Leap; Analysts High on Krystal Despite Revenue Miss appeared first on GEN - Genetic…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}